240 related articles for article (PubMed ID: 18414107)
61. Efficacy and tolerability of fixed-combination brinzolamide/timolol in Latin American patients with open-angle glaucoma or ocular hypertension previously on brimonidine/timolol fixed combination.
Alezzandrini A; Hubatsch D; Alfaro R
Adv Ther; 2014 Sep; 31(9):975-85. PubMed ID: 25138224
[TBL] [Abstract][Full Text] [Related]
62. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial.
Brandt JD; VanDenburgh AM; Chen K; Whitcup SM;
Ophthalmology; 2001 Jun; 108(6):1023-31; discussion 1032. PubMed ID: 11382623
[TBL] [Abstract][Full Text] [Related]
63. A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.
Denis P; Andrew R; Wells D; Friren B
Eur J Ophthalmol; 2006; 16(3):407-15. PubMed ID: 16761242
[TBL] [Abstract][Full Text] [Related]
64. Safety and efficacy of monotherapy change to fixed combination (travoprost 0.004%/timolol 0.5%) in 6 months follow up period.
Mandić Z; Novak-Laus K; Bojić L; Popović-Suić S; Ekert M; Dosen VM; Pelcić G; Clementi D; Dobutović D; Biuk D; Iveković R; Kovacić Z; Pavan J; Susić N; Geser MZ; Krolo I; Barisić F; Jurić-Miletić A; Dogan KK; Tomić M; Kovacević S
Acta Clin Croat; 2010 Dec; 49(4):411-9. PubMed ID: 21830452
[TBL] [Abstract][Full Text] [Related]
65. Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combination.
Day DG; Sharpe ED; Beischel CJ; Jenkins JN; Stewart JA; Stewart WC
Eur J Ophthalmol; 2005; 15(3):336-42. PubMed ID: 15945001
[TBL] [Abstract][Full Text] [Related]
66. Comparison of evening and morning dosing of travoprost 0.004%/timolol 0.5% fixed combination in 6 month period.
Suić SP; Laus KN; Dosen VM; Ekert M; Mandić Z; Bojić L
Coll Antropol; 2010 Sep; 34(3):847-52. PubMed ID: 20977071
[TBL] [Abstract][Full Text] [Related]
67. A 12-month, multicenter, randomized, double-masked, parallel-group comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertension.
Mundorf TK; Ogawa T; Naka H; Novack GD; Crockett RS;
Clin Ther; 2004 Apr; 26(4):541-51. PubMed ID: 15189751
[TBL] [Abstract][Full Text] [Related]
68. Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting.
Park KH; Simonyi S; Kim CY; Sohn YH; Kook MS
BMC Ophthalmol; 2014 Dec; 14():160. PubMed ID: 25519810
[TBL] [Abstract][Full Text] [Related]
69. Adherence to Fixed-Combination Versus Unfixed Travoprost 0.004%/Timolol 0.5% for Glaucoma or Ocular Hypertension: A Randomized Trial.
Barnebey HS; Robin AL
Am J Ophthalmol; 2017 Apr; 176():61-69. PubMed ID: 27993589
[TBL] [Abstract][Full Text] [Related]
70. Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management.
Laibovitz RA; VanDenburgh AM; Felix C; David R; Batoosingh A; Rosenthal A; Cheetham J
Arch Ophthalmol; 2001 Jul; 119(7):994-1000. PubMed ID: 11448321
[TBL] [Abstract][Full Text] [Related]
71. Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study.
Feuerhake C; Buchholz P; Kimmich F
Curr Med Res Opin; 2009 Apr; 25(4):1037-43. PubMed ID: 19290780
[TBL] [Abstract][Full Text] [Related]
72. A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.
Sharpe ED; Williams RD; Stewart JA; Nelson LA; Stewart WC
J Ocul Pharmacol Ther; 2008 Aug; 24(4):408-13. PubMed ID: 18627340
[TBL] [Abstract][Full Text] [Related]
73. Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials.
Aptel F; Cucherat M; Denis P
Eur J Ophthalmol; 2012; 22(1):5-18. PubMed ID: 22167538
[TBL] [Abstract][Full Text] [Related]
74. Bimatoprost/timolol versus travoprost/timolol fixed combinations in an Egyptian population: a hospital-based prospective randomized study.
Macky TA
J Glaucoma; 2014; 23(8):561-6. PubMed ID: 23429621
[TBL] [Abstract][Full Text] [Related]
75. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
Agarwal HC; Gupta V; Sihota R
J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055
[TBL] [Abstract][Full Text] [Related]
76. Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Belfort R; Paula JS; Lopes Silva MJ; Della Paolera M; Kim T; Chen MY; Goodkin ML
Clin Ther; 2020 Feb; 42(2):263-275. PubMed ID: 32089329
[TBL] [Abstract][Full Text] [Related]
77. Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
Paranhos A; Mendonça M; Silva MJ; Giampani J; Torres RJ; Della Paolera M; Russ H; Lottenberg CL
J Ocul Pharmacol Ther; 2010 Dec; 26(6):611-5. PubMed ID: 21029020
[TBL] [Abstract][Full Text] [Related]
78. Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study.
Brandt JD; Sall K; DuBiner H; Benza R; Alster Y; Walker G; Semba CP;
Ophthalmology; 2016 Aug; 123(8):1685-1694. PubMed ID: 27157843
[TBL] [Abstract][Full Text] [Related]
79. Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension.
Peace JH; Ahlberg P; Wagner M; Lim JM; Wirta D; Branch JD
Am J Ophthalmol; 2015 Aug; 160(2):266-274.e1. PubMed ID: 25935098
[TBL] [Abstract][Full Text] [Related]
80. Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertension.
Williams RD; Novack GD; van Haarlem T; Kopczynski C;
Am J Ophthalmol; 2011 Nov; 152(5):834-41.e1. PubMed ID: 21794845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
